Add to ORKGDaily supplementation of D-ribose shows no therapeutic benefits in the MHC-I transgenic mouse model of inflammatory myositi
Mucopolysaccharidosis type I (MPS I) is the most common form of the MPS group of genetic diseases. M...
Thymosin beta-4 (Tbeta4) is a ubiquitous protein with many properties relating to cell proliferation...
Duchenne muscular dystrophy is an X-linked, recessive muscular dystrophy in which the absence of the...
BACKGROUND: Current treatments for idiopathic inflammatory myopathies (collectively called myositis)...
<div><p>Background</p><p>Current treatments for idiopathic inflammatory myopathies (collectively cal...
Background Current treatments for idiopathic inflammatory myopathies (collectively called myositis) ...
<p>Data from four treatment groups are shown: Healthy untreated mice (H, n = 8), healthy mice given ...
<p>After mice were sacrificed, RNA was isolated from the quadriceps muscle tissue and used to determ...
<p>After mice were sacrificed at 16 weeks of age, quadriceps tissue was sectioned and stained with H...
<p>Body weights for mice were recorded starting at the time of D-ribose administration. Mice were sa...
Polymyositis (PM) is a chronic autoimmune inflammatory myopathy resulting in muscle weakness. The li...
Glucocorticoids delay muscle wasting in Duchenne Muscular Dystrophy by reducing inflammation; but al...
The inclusion body myositis is the most frequent acquired myopathy of the patient collective beyond ...
International audiencePolymyositis is a rare and severe inflammatory muscle disorder. Treatments are...
We developed an experimental autoimmune myositis (EAM) mouse model of polymyositis where we outlined...
Mucopolysaccharidosis type I (MPS I) is the most common form of the MPS group of genetic diseases. M...
Thymosin beta-4 (Tbeta4) is a ubiquitous protein with many properties relating to cell proliferation...
Duchenne muscular dystrophy is an X-linked, recessive muscular dystrophy in which the absence of the...
BACKGROUND: Current treatments for idiopathic inflammatory myopathies (collectively called myositis)...
<div><p>Background</p><p>Current treatments for idiopathic inflammatory myopathies (collectively cal...
Background Current treatments for idiopathic inflammatory myopathies (collectively called myositis) ...
<p>Data from four treatment groups are shown: Healthy untreated mice (H, n = 8), healthy mice given ...
<p>After mice were sacrificed, RNA was isolated from the quadriceps muscle tissue and used to determ...
<p>After mice were sacrificed at 16 weeks of age, quadriceps tissue was sectioned and stained with H...
<p>Body weights for mice were recorded starting at the time of D-ribose administration. Mice were sa...
Polymyositis (PM) is a chronic autoimmune inflammatory myopathy resulting in muscle weakness. The li...
Glucocorticoids delay muscle wasting in Duchenne Muscular Dystrophy by reducing inflammation; but al...
The inclusion body myositis is the most frequent acquired myopathy of the patient collective beyond ...
International audiencePolymyositis is a rare and severe inflammatory muscle disorder. Treatments are...
We developed an experimental autoimmune myositis (EAM) mouse model of polymyositis where we outlined...
Mucopolysaccharidosis type I (MPS I) is the most common form of the MPS group of genetic diseases. M...
Thymosin beta-4 (Tbeta4) is a ubiquitous protein with many properties relating to cell proliferation...
Duchenne muscular dystrophy is an X-linked, recessive muscular dystrophy in which the absence of the...